Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000156

Director sold 30,688 shares at an average $22.11 ($678,660)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-13 Sale : show line 1 in the form 10b5-1 −688 $21.79 $14,992 52,620 D
2024-07-01 Sale : show line 2 in the form 10b5-1 −29,900 $22.12 $661,388 34,504 D
2024-07-01 Sale : show line 3 in the form 10b5-1 −100 $22.80 $2,280 34,404 D
Open-market sales · 30,688 sh · avg $22.11 · $678,660
Loading xslF345X05/wk-form4_1720055619.xml…